[Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000863:Antacids / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000627:therapeutic use; D004751:Enteritis / Q000188:drug therapy*; D005260:Female; D005759:Gastroenteritis / Q000188:drug therapy*; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*
D000863:Antacids; D001555:Benzene Derivatives; D006571:Heterocyclic Compounds
Considerazioni cliniche sull'effetto terapeutico di un nuovo preparato antisecretivo non anticolinergico: Milid (xylamide-CR 242)